-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BAgMxKgvu37iQKj9T8rJ1Nd+D/UhjhXfgaQSRSmjmE7DiwaJKPZ7pb+2mGI3YS7B j82b8CO71+C2XfdJd3iNDw== 0000922423-10-000511.txt : 20101110 0000922423-10-000511.hdr.sgml : 20101110 20101110162222 ACCESSION NUMBER: 0000922423-10-000511 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101110 DATE AS OF CHANGE: 20101110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81212 FILM NUMBER: 101180345 BUSINESS ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GILDER GAGNON HOWE & CO LLC CENTRAL INDEX KEY: 0000902464 IRS NUMBER: 133174112 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127652500 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GILDER GAGNON HOWE & CO DATE OF NAME CHANGE: 19930428 SC 13G 1 kl11009.htm SCHEDULE 13G kl11009.htm  




SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
                   
 
SCHEDULE 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments
Thereto Filed Pursuant to  § 240.13d-2.
 
Under the Securities Exchange Act of 1934


      NxStage Medical, Inc.
(Name of Issuer)
 
          Common Stock         
(Title of Class of Securities)
 
         67072V103          
(CUSIP Number)
 
                        October 31, 2010                     
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
ý  Rule 13d-1(b)
¨  Rule 13d-1(c)
¨  Rule 13d-1(d)
 
                  
 
Page 1 of 6 Pages

 
 

 

SCHEDULE 13G
 
CUSIP No. 67072V103                                                       Page 2 of 6 Pages
 
1)
NAME OF REPORTING PERSON
 
Gilder, Gagnon, Howe & Co. LLC
 
2)
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       o
(b)       o
3)
SEC USE ONLY
 
 
4)
CITIZENSHIP OR PLACE OF ORGANIZATION
 
New York
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5)
SOLE VOTING POWER
 
64,461
6)
SHARED VOTING POWER
 
None
7)
SOLE DISPOSITIVE POWER
 
64,461
8)
SHARED DISPOSITIVE POWER
 
3,169,102
9)
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,233,563
10)
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
o
11)
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
6.7%
12)
TYPE OF REPORTING PERSON
 
BD
 

 

 
 

 

Schedule 13G
 
Item 1(a).
Name of Issuer:
 
NxStage Medical, Inc.
 
Item 1(b).               Address of Issuer’s Principal Executive Offices:
 
439 South Union Street, 5th Floor
Lawrence, MA 01843

Item 2(a).               Name of Person Filing:

Gilder, Gagnon, Howe & Co. LLC
 
Item 2(b).
Address of Principal Business Office or, if None, Residence:
 
3 Columbus Circle, 26th Floor
New York, NY 10019
 
Item 2(c).
Citizenship:
 
New York
 
Item 2(d).
Title of Class of Securities:
 
Common Stock
 
Item 2(e).
CUSIP Number:
 
67072V103 
 
Item 3.                    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
x
Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
 
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
 
 
(c)
¨
Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
 
 
(d)
¨
Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
 
 
(e)
¨
Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
 
 
(f)
¨
Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
 
 
(g)
¨
Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
 
 
 
 

 
 
 
 
(h)
¨
Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
 
 
(i)
¨
Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
 
 
(j)
¨
Group, in accordance with §240.13d-1(b)(ii)(J)
 
Item 4.
Ownership.
 
 
(a)
Amount beneficially owned:  3,233,563
 
 
(b)
Percent of class: 6.7%
 
 
(c)
Number of shares as to which such person has:
 
 
(i)
Sole power to vote or to direct the vote:  64,461
 
 
(ii)
Shared power to vote or to direct the vote:  None
 
 
(iii)
Sole power to dispose or to direct the disposition of:  64,461
 
 
(iv)
Shared power to dispose or to direct the disposition of:  3,169,102
 
 
The shares reported include 2,863,993 shares held in customer accounts over which partners and/or employees of the Reporting Person have discretionary authority to dispose of or direct the disposition of the shares, 305,109 shares held in accounts owned by the partners of the Reporting Person and their families, and 64,461 shares held in the account of the profit-sharing plan of the Reporting Person (the “Profit-Sharing Plan”).
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
Not applicable
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.

The owners of the accounts (including the Profit-Sharing Plan) in which the shares reported on this Schedule are held have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
Not applicable
 

 
 
 

 

 
Item 8.
Identification and Classification of Members of the Group.
 
Not applicable
 
Item 9.
Notice of Dissolution of Group.
 
Not applicable
 
Item 10.
Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 

 
 
 

 

SIGNATURE
 
After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
 
 
November 8, 2010                                                                       
   Date
 
 
/s/ Scott I. Noah                                                                        
   Signature
 
 
Scott I. Noah, General Counsel & Chief Compliance Officer
   Name/Title
 

 
 
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----